Compare Danaher Corporation (DHR) vs Otis Worldwide Corp (OTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Otis Worldwide Corp — how do they compare? Danaher Corporation trades at $201.01 (market cap $140.88B), while Otis Worldwide Corp trades at $72.05 (market cap $27.84B). The key difference: Danaher Corporation is far larger — about 5.1× Otis Worldwide Corp's market cap, and Otis Worldwide Corp pays the higher dividend (2.34%). Which is the better fit depends on your goals.
| DHR | OTIS | |
|---|---|---|
Market Cap | $140.88B | $27.84B |
Sector | Health | Industrials |
52-Week High | $242.05 | $101.07 |
52-Week Low | $161.91 | $69.34 |
Enterprise Value | $153.66B | $35.23B |
Dividend Yield | 0.8% | 2.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, down 0.55% today, with a bullish technical outlook supported by moving averages and a consensus price target of $211.33. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.06 exceeding expectations. Revenue for 2025 was $24.57 billion, with a net income margin of 14.89%, though margins have declined from 2022 levels. Recent news includes the acquisition of Masimo and strong biotechnology segment performance.
The stock presents a favorable risk-reward profile with analyst support (69% buy ratings) and solid cash flow generation, but faces risks from margin compression and a high P/E ratio of 38.58. Upside is driven by earnings beats and strategic acquisitions, while headwinds include competitive pressures and macroeconomic uncertainty. The current price near $199 offers modest upside to the consensus target, with key resistance at $200.
Otis Worldwide trades at $73.42, up 0.45% today, with a bullish technical signal from moving averages but mixed quarterly earnings. The company maintains stable revenue near $14.4B (2025) and a net margin of 10.11%, supported by service growth and modernization initiatives like recent upgrades at Christ the Redeemer in Brazil. Cash flow from operations remains strong at $1.6B, though net cash flow turned negative in 2025 due to financing activities.
The stock offers 24% upside to the consensus price target of $91.00, with analysts divided (38% Buy, 54% Hold). Risks include debt levels (75.54% debt-to-asset ratio) and margin pressure from tariffs, but dividend growth (5% increase to $0.44) and buybacks provide shareholder value. Near-term performance hinges on Q2 2026 earnings due July 22, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →
